IBRI Signs a License Agreement with Eli Lilly to Access its Fab Phage Display Library
Shots:
- The Indiana Biosciences Research Institute collaborates with Lilly to identify new Ab & to validate new diagnostics by utilizing Lilly’s Fab Phage Display Library- advancing innovations from discovery to the clinic
- The collaboration will speed up the discovery and validation of new antibodies and enhances IBRI’s capabilities to develop Ab targeting range of diseases
- Lilly’s Phage Display Library is a cornerstone technology which serves a large database of known bacteriophages and contains the genetic information that encodes them and is used to discover & develop novel biotherapies
Ref: GlobeNewsWire | Image: Eli Lilly
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com